Ultrasound-visible clips prove practical, cost-effective for guiding breast surgery

Biopsy clips can outperform conventional wires for localizing breast cancers, as the former may boost utilization of ultrasound guidance for tumor resection, in the process minimizing patient discomfort while helping control costs.

That’s according to researchers at the University of Vermont who compared localization techniques. Their findings were published online Nov. 18 in the Journal of Ultrasound in Medicine.

Senior study author Michelle Sowden, DO, and colleagues analyzed data on 2,209 patients who had a breast biopsy at their institution over a three-year period ending in 2016.

In patients with breast cancer, the team found, the placement of ultrasound-visible clips during biopsy increased the use of ultrasound during tumor resection by 13%.

Additionally, biopsy specimen volumes were no greater with the clips than with wire localization.

Meanwhile the team found a savings of $36,000 associated with the use of ultrasound-visible clips.

The authors suggest that ultrasound guidance combined with ultrasound-visible clips may constitute a best practice for patients undergoing breast surgery.   

“In partial mastectomy or lumpectomy, ultrasound localization avoids discomfort and additional procedures associated with wire localization,” they wrote. “Placement of an ultrasound-visible clip at the time of biopsy is recommended, as it is costeffective and avoids the discomfort and inconvenience of wire localization.”  

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.